A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia

Overview of attention for article published in Drug Design, Development and Therapy, March 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 33 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 5,324 followers.

RT @DovePress: A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia https://t.co…

Reply Repost Favourite

A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia https://t.co/TRnnFRHcTF

Reply Repost Favourite

A First-in-Human Dose Finding Study of Camrelizumab https://t.co/HdawOXRjZC

Reply Repost Favourite